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Abstract
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The metabolite 2-hydroxyglutarate (2HG) can be produced as either a D(R)- or L(S)- enantiomer,
each of which inhibits alpha-ketoglutarate (αKG)-dependent enzymes involved in diverse biologic
processes. Oncogenic mutations in isocitrate dehydrogenase produce D-2HG, which causes a
pathologic blockade in cell differentiation. On the other hand, oxygen limitation leads to
accumulation of L-2HG, which can facilitate physiologic adaptation to hypoxic stress in both
normal and malignant cells. Here we demonstrate that purified lactate dehydrogenase (LDH) and
malate dehydrogenase (MDH) catalyze stereospecific production of L-2HG via ‘promiscuous’
reduction of the alternative substrate αKG. Acidic pH enhances production of L-2HG by
promoting a protonated form of αKG that binds to a key residue in the substrate-binding pocket of
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LDHA. Acid-enhanced production of L-2HG leads to stabilization of hypoxia-inducible factor 1
alpha (HIF-1α) in normoxia. These findings offer insights into mechanisms whereby
microenvironmental factors influence production of metabolites that alter cell fate and function.
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The discovery of oncogenic mutations in IDH enzymes demonstrated the profound impact
that altered metabolism can have on cell identity and function1,2. Mutant IDH enzymes
efficiently catalyze reduction of αKG to the ‘oncometabolite’ D-2HG3,4. D-2HG inhibits a
large family of >70 different αKG-dependent enzymes that regulate chromatinmodifications, stability of hypoxia-inducible factors, extracellular matrix maturation, and
DNA repair1. In particular, D-2HG-mediated inhibition of chromatin-modifying enzymes
impairs induction of gene expression programs required for normal cell differentiation and
‘locks’ malignant cells in an undifferentiated stem cell-like state5–7. The relative
contributions of different D-2HG targets to oncogenesis likely varies depending on the
cellular context8,9.

Author Manuscript

While intensive efforts have been directed at investigating the molecular and cellular effects
of IDH mutant-derived D-2HG, potential sources and functions of the mirror-image
enantiomer L-2HG are less well understood10. Importantly, biochemical assays
demonstrated that L-2HG functions as a more potent inhibitor of αKG-dependent enzymes
compared to D-2HG; thus cells may be quantitatively more sensitive to changes in L-2HG
than D-2HG11–13. Indeed, deregulated L-2HG disposal causes significant developmental
pathology and is associated with brain and kidney cancer14–16.
It was recently reported that hypoxia induces production of L-2HG by both normal and
malignant cells as a physiologic response to oxygen limitation17,18. Hypoxia-induced
production of L-2HG occurs independently of HIF but acts to reinforce the hypoxic
response, at least in part, through stabilization of HIF protein13,17,18. Accumulation of
L-2HG slows glycolysis and mitochondrial respiration by reducing the regeneration of
NAD+18. Moreover, hypoxia-induced L-2HG promotes the same repressive chromatin marks
that characterize the differentiation blockade of IDH-mutant malignancies8,17,19, consistent
with the well established association between hypoxic niches and stem cell populations20.

Author Manuscript

Genetic evidence suggests that lactate dehydrogenase and malate dehydrogenase enzymes
are major sources of hypoxia-induced L-2HG16–18,21, but there has been no demonstration
that these enzymes directly catalyze L-2HG production. Here we demonstrate that purified
LDH and MDH enzymes can catalyze stereospecific reduction of αKG to L-2HG and that
acidic reaction conditions dramatically enhance LDH- and MDH-mediated production of
L-2HG in vitro and in cells. Mechanistically, acidic pH enhances LDHA-mediated reduction
of αKG by driving equilibrium toward a protonated form of αKG that binds more stably to
the LDHA enzyme. In living cells, the pH-dependent induction of L-2HG acts as a potent
stabilizer of HIF-1α in normoxia, representing a previously unknown pathway of HIF-1α
stabilization with potential relevance to human disease states. These findings offer new
Nat Chem Biol. Author manuscript; available in PMC 2017 September 06.
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insights in the mechanisms that regulate non-canonical substrate use by metabolic enzymes
and the consequences of promiscuous L-2HG production in cell physiology.

Results
LDH and MDH enzymes use αKG as an alternative substrate

Author Manuscript

Hypoxic cells undergo a number of metabolic changes (Fig. 1a) including an increased
NADH/NAD+ ratio18,22, an increased intracellular concentration of αKG18,23, and
acidification of the extracellular and intracellular environments24,25. Prior reports implicated
lactate dehydrogenase A (LDH) and malate dehydrogenase 1 and 2 (MDH) as contributing
to hypoxia-induced L-2HG in cells (Fig. 1a)17,18. To determine if these enzymes could
directly produce L-2HG, we tested the ability of purified LDH and MDH to catalyze
NADH-dependent reduction of their canonical substrates as well as αKG. As expected,
LDH rapidly consumed NADH in the presence of its canonical substrate pyruvate (Fig. 1b).
LDH also consumed NADH in the presence of αKG confirming its capacity to utilize
alternative larger alpha-ketoacid substrates (Fig. 1b)26,27. Likewise, MDH efficiently
catalyzed reduction of its canonical substrate oxaloacetate (Fig. 1c), while also
demonstrating an ability to use αKG as a non-canonical substrate, albeit less efficiently (Fig.
1c).

Author Manuscript

We performed gas chromatography-mass spectrometry (GC-MS) to determine the identities
of the alpha-hydroxyacid reaction products generated by LDH and MDH enzymes. Analysis
of reaction mixtures without enzyme demonstrated that there was no significant nonenzymatic production of lactate, malate, or 2HG (Fig. 1d–f). LDH, but not MDH, catalyzed
reduction of pyruvate to lactate (Fig. 1d). Both MDH and LDH catalyzed reduction of
oxaloacetate to malate, with MDH catalyzing this reaction more efficiently than LDH, as
expected (Fig. 1e). Notably, both LDH and MDH enzymes were capable of ‘promiscuously’
catalyzing NADH-dependent reduction of the alternative substrate αKG to 2HG (Fig. 1f).
LDH and MDH catalyze reduction of αKG to L-2HG

Author Manuscript

Standard metabolite derivatization and chromatography methods do not distinguish between
enantiomeric species. In order to separate alpha-hydroxyacid enantiomers, we adapted a
liquid chromatography-mass spectrometry (LC-MS) protocol involving derivatization of
metabolites with the chiral compound diacetyl-L-tartaric anhydride (Supplementary Results,
Supplementary Fig. 1)28. The identity of alpha-hydroxyacid enantiomers was confirmed by
comparison to similarly derivatized standards (Fig. 2a–c). As expected, chiral derivatization
showed that LDH catalyzed reduction of pyruvate to L-lactate, whereas MDH catalyzed this
reaction poorly (Fig. 2a). MDH catalyzed its canonical reaction involving reduction of
oxaloacetate to L-malate (Fig. 2b), while LDH catalyzed this reaction less effectively (Fig.
2b). Both LDH and MDH catalyzed stereospecific reduction of αKG to L-2HG (Fig. 2c and
Supplementary Fig. 2). To ensure that L-2HG production was not facilitated by an unknown
contaminant of the enzyme preparations (Supplementary Fig. 3a), we also studied
recombinant human LDHA, MDH1, and MDH2 enzymes. The recombinant enzymes also
catalyzed stereospecific reduction of αKG to L-2HG (Supplementary Fig. 3b–f).

Nat Chem Biol. Author manuscript; available in PMC 2017 September 06.
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Collectively, these findings substantiate genetic evidence suggesting that LDH and MDH
enzymes contribute to cellular production of L-2HG16–18,21.
Wildtype IDH and PHGDH enzymes produce D-2HG

Author Manuscript

Prior reports demonstrated that wildtype isocitrate dehydrogenase enzymes can catalyze
reduction of αKG to 2HG but the stereochemistry of the 2HG product was not
determined29,30. Therefore, we sought to assess whether wildtype IDH enzymes might
represent another cellular source of D- or L-2HG. Using a cell-based assay, we observed that
transfection with empty vector had no effect on D- or L-2HG levels, whereas transfection
with wildtype IDH1 or IDH2 selectively increased D-2HG levels (Supplementary Fig. 4a, b
and 5). Supplementation with cell-permeable αKG substrate resulted in a further increase in
the amount of D-2HG in cells transfected with wildtype IDH1 or IDH2 (Supplementary Fig.
4a, b and 5), albeit ~50–100 fold less than that observed in cells transfected with an
oncogenic IDH1 R132H mutant (Supplementary Fig. 4c).

Author Manuscript

Commercially available preparations of IDH from porcine heart were impure and thus
unsuitable for enzymatic assays, prompting us to use recombinant human IDH1 as an
alternative (Supplementary Fig. 3a). Employing previously reported reaction conditions with
Tris-based buffers31, we detected substantial non-enzymatic production of 2HG that was
equally distributed as D- and L- enantiomers (Supplementary Fig. 6). In contrast, nonenzymatic 2HG production was negligible in phosphate-based reaction buffers
(Supplementary Fig. 6). Using phosphate-based buffers, we found that recombinant human
IDH1 selectively catalyzed production of D-2HG (Supplementary Fig. 4d). Taken together,
the cell-based and recombinant enzyme assays demonstrate that wildtype IDH enzymes can
catalyze production of D-2HG, an intrinsic enzymatic property that is substantially enhanced
by the active site arginine residue mutations in IDH observed in cancer29,30.
The enzyme 3-phosphoglycerate dehydrogenase (PHGDH) was recently identified as
another potential cellular source of D-2HG32,33. Indeed, we found that recombinant human
PHGDH catalyzed stereospecific reduction of αKG to D-2HG in vitro (Supplemental Fig.
4e). The locus encoding PHGDH is frequently amplified in breast cancer and
melanoma34,35, and elevated 2HG levels have been detected in primary breast tumors with
aggressive features but no IDH mutation36. Thus, determining the chirality of 2HG should
help elucidate which metabolic pathway contributes to 2HG production in various cancer
settings.
Acidic pH enhances alternative enzymatic activity of LDH

Author Manuscript

When investigating the enzymatic properties of LDH, we noted a striking enhancement in
NADH-dependent reduction of αKG at more acidic pH (Fig. 3a). Specifically, the Km of
LDH for αKG decreased from >15 mM at pH 7.4 to 3.86 ± 0.97 mM at pH 6.0 (Fig. 3c), a
value that approximates the concentration of αKG in hypoxic cells18. We found that the
enhanced rate of αKG-dependent NADH consumption at more acidic pH resulted in
increased LDH-dependent production of L-2HG (Fig. 3e). Acidification also enhanced the
ability of MDH to catalyze reduction of αKG to L-2HG, albeit to a lesser degree (Fig. 3b, d,
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f). Although the rate of non-enzymatic NADH degradation increased at acidic pH, there was
no detectable non-enzymatic production of L-2HG (Supplementary Fig. 7).
In contrast to the effects on non-canonical substrate usage, acidic pH had no substantial
effect on the ability of LDH to reduce its canonical substrate pyruvate at a near physiologic
pyruvate concentration of 0.3 mM (Fig. 3g)37. At concentrations of pyruvate greater than 0.3
mM, acidic pH impaired the ability of LDH to reduce pyruvate due to enhanced substrate
inhibition as previously described (Fig. 3g, h)38. Together, these results demonstrate that
acidification enhances the alternative substrate utilization of lactate dehydrogenase such that
the non-canonical substrate αKG is relatively favored at lower pH, resulting in increased
production of L-2HG.

Author Manuscript

We also examined the effects of acidic pH on the ability of wildtype IDH1 and PHGDH to
reduce αKG to D-2HG. Wildtype IDH1 exhibited minimal pH-dependent change in D-2HG
production (Supplementary Fig. 8a). In contrast, PHGDH exhibited enhancement of D-2HG
production in acidic pH (Supplementary Fig. 8b).
Acidity enhances reduction of a subset of alpha-ketoacids

Author Manuscript

To determine whether acidic pH might increase accessibility to the substrate-binding pocket
of LDH, we tested the effect of pH on LDH-mediated reduction of alpha-ketoacids with
bulky tail groups, including phenylpyruvate (PP) and hydroxyphenylpyruvate (HPP) (Fig.
4a). We observed that LDH reduced both PP and HPP at a rate at least as great as that of
αKG, and there were no substantial pH-dependent changes in the rate of reduction for either
substrate (Fig. 4a). These findings suggest that acidic pH does not function merely to
enhance access for substrates larger than pyruvate, such as αKG, to the substrate-binding
pocket of LDH.
We investigated whether the nature of the chemical moiety present in the tail end of the
alpha-ketoacid substrate might dictate the pH-dependent properties of the LDH enzymatic
reaction. We identified pairs of alpha-ketoacid substrates of identical carbon-chain length
that differed only in whether there was a carboxylate or methyl group present in the final
position (Fig. 4b), including oxaloacetate (OAA; 4-carbon), alpha-ketoglutarate (αKG; 5carbon), and oxoadipic acid (OAdA; 6-carbon) along with their respective methylated
counterparts alpha-ketobutyrate (αKB; 4-carbon), oxopentanoic acid (OPA; 5-carbon), and
ketohexanoic acid (KHA; 6-carbon). For each substrate pair, only the alpha-ketoacid with a
carboxylate group in the final position exhibited pH-dependent enhancement of enzymatic
reduction (Fig. 4b).

Author Manuscript

Acidification enhances interaction of αKG with LDHA Q100
We performed Monte Carlo protonation state modeling simulations with virtually docked
substrates to determine whether pH-dependent changes in the protonation states of αKG,
NADH, or LDHA might be responsible for the acid-enhanced enzymatic reduction of αKG.
The docked structure of αKG demonstrated that the carboxylate group in the tail of the
substrate is positioned immediately adjacent to glutamine 100 (Q100) in the substratebinding pocket of LDHA (Fig. 5a). Prior reports demonstrated that the corresponding
residue in bacterial LDH plays an important role in determining substrate specificity39,40.
Nat Chem Biol. Author manuscript; available in PMC 2017 September 06.
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Analysis of the Monte Carlo simulations demonstrated a change of the predominant
protonation state of αKG upon binding LDHA with NADH. The carboxylate tail of αKG
has a predicted pKa of 4.28 ± 1.27 (closely matching the experimental pKa of 4.4)41,
indicating that it would be mostly deprotonated in solution at pH values ranging from 6.0 to
7.4. However, upon binding to LDHA, the carboxylate tail of αKG becomes protonated
whereupon it is predicted to form a hydrogen bond with Q100 (Fig. 5b). This is associated
with a free energy penalty for protonating the carboxylate tail that opposes binding, which
for a given pH can be expressed as

Author Manuscript

where is the Boltzmann constant and T equals the absolute temperature. Protonating the
carboxylate tail at pH 7.4 would cost 3.2 kBT more than protonating it at pH 6.0 (Fig. 5c).
The expected fold change in the aqueous concentration of the deprotonated form is
calculated as follows:

If the enzyme greatly prefers to bind the protonated form, then the predicted Km of αKG
would be approximately 25 times higher (lower affinity) at pH 7.4 than at 6.0, absent
additional pH-dependent effects. These predictions are consistent with the increased Km
measured experimentally for αKG at pH 7.4 compared to pH 6.0 (Fig. 3c).

Author Manuscript

Mutation of Q100 to a positively charged amino acid might alter the substrate preference for
LDHA, such that it would favor αKG with the carboxylate tail in the deprotonated
(negatively charged) state, thus abolishing the pH trend observed with the wildtype LDHA
enzyme. Indeed, mutation of the corresponding residue in bacterial LDH from glutamine to
arginine (Q102R) enhanced the ability of the enzyme to reduce oxaloacetate39,40. Therefore,
we generated vectors expressing either wildtype LDHA (LDHA WT) or LDHA with a point
mutation resulting in replacement of glutamine 100 with arginine (LDHA Q100R). The
constructs were transfected into 293T cells, and the FLAG-tagged enzymes were purified by
immunoprecipitation (Supplementary Fig. 9). Equal quantities of enzyme were used for in
vitro reactions with NADH cofactor and the substrates alpha-ketoglutarate (αKG),
oxopentanoic acid (OPA), pyruvate (Pyr), and oxaloacetate (OAA; Fig. 5d–g).

Author Manuscript

In contrast to the acid-enhanced reduction of αKG mediated by wildtype LDHA, the LDHA
Q100R mutant exhibited a relatively faster rate of αKG reduction at higher pH values with
no enhancement of activity as the pH decreased (Fig. 5d). Thus the positive charge of the
Q100R appears to eliminate the energetic penalty normally required to protonate the
carboxylate tail of αKG. In contrast, the LDHA Q100R mutant exhibited relatively impaired
enzymatic reduction of oxopentanoic acid, which has a methyl group in the tail position
(Fig. 5f). Likewise, the LDHA Q100R mutant exhibited a relative preference for
oxaloacetate (Fig. 5e) and a relatively impaired ability to reduce pyruvate (Fig. 5g). Taken
together, these findings suggest that acidic pH enhances the ability of wildtype LDHA to
Nat Chem Biol. Author manuscript; available in PMC 2017 September 06.
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reduce substrates with a carboxylate group in the final position by diminishing the energetic
penalty of protonating the substrate tail to accommodate binding with glutamine 100 in the
LDHA substrate-binding pocket. The LDHA Q100R mutant introduces a positively charged
residue at the Q100 site, which alters substrate preference such that alpha-ketoacids with
carboxylate tails need not pay the energetic cost of being protonated to bind and are
relatively favored at higher pH values.
Acid-enhanced production of L-2HG stabilizes HIF-1α

Author Manuscript

Given the striking enhancement of LDH-catalyzed L-2HG production observed in vitro, we
sought to determine the effects of acidification on 2HG production in cells. Cells grown in
normoxic conditions were lysed in non-denaturing buffer with pH ranging from 7.5 to 6.0
(Fig. 6a). Cell lysates were used as a source of enzyme for in vitro reactions with addition of
αKG and NADH, and 2HG production was assessed by GC-MS. As the reaction pH was
lowered, there was a progressive increase in the amount of 2HG produced, such that there
was >3 fold more 2HG at pH 6.0 compared to pH 7.5 (Fig. 6a). Assessment of chirality by
LC-MS confirmed that acidification of cell lysate reactions potently induced production of
L-2HG (Fig. 6b). Acid-enhanced L-2HG production was blocked by addition of oxamate, a
lactate dehydrogenase inhibitor that is a structural analog of pyruvate (Fig. 6b)42. Thus, acidenhanced production of L-2HG depends, at least in part, on the enzymatic activity of LDH.

Author Manuscript

Hypoxia results in acidification of the cellular environment and an increase in the
intracellular concentration of αKG (Fig. 1a)18,23–25, but it is unclear to what extent these
conditions might be sufficient to induce production of L-2HG. Therefore, we tested the
effects of acidified medium and/or exogenous αKG on cells cultured in normoxia (Fig. 6c).
As previously reported, addition of cell-permeable αKG resulted in a modest increase in
2HG production in cells cultured in standard medium in normoxia (Fig. 6c)17. However, we
observed a synergistic enhancement of 2HG production when cells were cultured in
acidified medium supplemented with cell-permeable αKG (Fig. 6c). Quantification of the
intracellular concentrations of L- and D-2HG demonstrated that L-2HG levels exceeded 0.3
mM in acidified media supplemented with cell-permeable αKG (Fig. 6d), approximating
previous measurements in hypoxic cells17,18. In contrast, D-2HG concentrations were
approximately 10 fold lower (Fig. 6d). Measurement of intracellular pH with fluorescent
probes demonstrated a value of pH 6.53 ± 0.29 for cells cultured in acidic medium plus
αKG (Supplementary Fig. 10).

Author Manuscript

Cells cultured in acidic medium plus αKG demonstrated a striking stabilization of HIF-1α
despite the presence of atmospheric oxygen levels (Fig. 6c and Supplementary Fig. 11). The
observed stabilization of HIF-1α by αKG was paradoxical given the fact that αKG
functions as substrate for the EGLN enzymes that hydroxylate proline residues on HIF and
target it for proteasomal degradation43. Therefore, we examined the effects of acidification
plus αKG on the ratio of hydroxyl-HIF-1α to total HIF-1α in cells cultured in the presence
of the proteasome inhibitor MG132 (Fig. 6e and Supplementary Fig. 11)44. Cells cultured in
standard medium plus MG132 accumulated hydroxyl-HIF-1α relative to total HIF-1α in
response to cell-permeable αKG (Fig. 6e and Supplementary Fig. 11). In contrast, cells
cultured in acidified medium plus MG132 did not accumulate hydroxyl-HIF-1α despite a
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substantial increase in total HIF-1α protein (Fig. 6e and Supplementary Fig. 11). Thus, we
conclude that acid-enhanced L-2HG production stabilizes HIF-1α by inhibiting the αKGdependent prolyl hydroxylases that target HIF-1α for degradation, in agreement with
previously observed effects of L-2HG on prolyl hydroxylases in vitro11,13.

Author Manuscript

To further explore the possibility that acid-enhanced L-2HG lies upstream of HIF-1α, we
tested the effects of ablating LDHA and MDH2, the two enzymes primarily responsible for
L-2HG production in cells17,18. Cells treated with non-targeting control siRNA exhibited
normoxic stabilization of HIF-1α when cultured in acidic medium supplemented with αKG
(Fig. 6f and Supplementary Fig. 11). Ablation of either LDHA or MDH2 alone partially
impaired stabilization of HIF-1α in response to acidification (Supplementary Fig. 12a, b and
13). However, combined targeting of both LDHA and MDH2 abrogated L-2HG production
(Supplementary Fig. 12c) and abolished the ability of cells to stabilize HIF-1α in response
to acidification (Fig. 6f and Supplementary Fig. 11). These findings demonstrate that acidenhanced conversion of αKG to L-2HG by LDHA and MDH2 is sufficient to stabilize
HIF-1α in the absence of hypoxia.

Discussion

Author Manuscript

Herein we demonstrate that lactate dehydrogenase and malate dehydrogenase enzymes
catalyze ‘promiscuous’ enzymatic reduction of the alternative substrate αKG to L-2HG.
Decades-old studies demonstrated alternative substrate use by dehydrogenase enzymes but
lacked techniques to accurately assess the identity and chirality of metabolite products26,27.
Our findings indicate that there are multiple enzymes that can reduce αKG to 2HG and that
the chirality of 2HG is dictated by the specific enzyme involved. For example, LDH and
MDH enzymes catalyze stereospecific production of L-2HG, whereas wildtype (and mutant)
IDH and PHGDH catalyze stereospecific production of D-2HG.

Author Manuscript

The findings presented here substantiate prior genetic evidence implicating LDH and MDH
as cellular sources of L-2HG16–18,21. In hypoxia, cells selectively produce L-2HG in a
manner primarily dependent on LDHA and MDH217,18. The relative contributions of LDHA
and MDH2 to hypoxia-induced L-2HG appear to vary depending on the type of cell, which
may be related to enzyme levels and subcellular pools of substrate. Hypoxic cells undergo a
variety of metabolic changes that might favor L-2HG production18,22–25,45. Here we identify
acidification and increased αKG concentration as factors that are sufficient to induce cellular
production of L-2HG in normoxia. Indeed, in vitro enzymatic assays demonstrate that the
promiscuous enzymatic activity of LDH, and to a lesser extent MDH, is enhanced by acidic
pH, resulting in more efficient reduction of αKG to L-2HG. Acidic pH appears to enhance
LDHA-mediated reduction of αKG by driving equilibrium toward the protonated state of the
carboxylate tail, which permits docking of αKG via interaction with the glutamine 100 in
LDHA. Intracellular acidification might also explain, at least in part, the increased L-2HG
observed in cells with electron transport chain dysfunction46.
In hypoxia, L-2HG can function as a metabolic signaling molecule that mediates physiologic
responses to help cells adapt to oxygen limitation17,18. L-2HG acts to stabilize hypoxiainducible factors by inhibiting the αKG-dependent prolyl hydroxylases that target HIF for
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degradation11,13. Whether HIF-1α stabilization is a qualitatively or quantitatively unique
property of L-2HG compared to D-2HG remains controversial13,47,48. We have identified
acidosis as previously unappreciated physiologic stimulus that enhances conversion of αKG
to L-2HG, resulting in robust stabilization of HIF-1α in normoxia. HIF-1α facilitates
cellular adaptation to an acid load by inducing expression of carbonic anhydrases49, and our
findings suggest that acid-enhanced L-2HG may be part of this signaling axis. Indeed, we
find that ablation of LDHA and MDH2 abrogates the ability of acidotic cells to stabilize
HIF-1α. It is also possible that acidification and L-2HG cooperate in the stabilization of
HIF-1α50. Compared to L-2HG, we observed approximately 10 fold lower intracellular
concentrations of D-2HG. Given that L-2HG functions as a more potent inhibitor of αKGdependent enzymes than D-2HG11–13, we conclude that D-2HG derived from wildtype IDH
and/or PHGDH is negligible and likely does not play a physiologic role in this setting.

Author Manuscript

Promiscuous enzymatic activity results in the production of numerous metabolites that have
been described as ‘metabolite damage’ or mistakes10. However, emerging evidence suggests
that L-2HG, a metabolite produced by promiscuous enzyme activity, might represent a
conserved metabolic response to multiple environmental stimuli including hypoxia and
acidosis. L-2HG appears to mediate its effects through both HIF-dependent and HIFindependent mechanisms17,18. Future investigations will be directed at elucidating the
mechanisms whereby L-2HG regulates physiologic responses to hypoxia and acidosis, as
well as how deregulation of L-2HG metabolism might contribute to oncogenesis14,15.

Online Methods
Reagents

Author Manuscript

Purified enzymes were purchased from Sigma, including LDH from bovine heart (L2625),
LDH from rabbit muscle (L2500), and MDH from porcine heart (M1567). Recombinant
human enzymes were purchased from Abcam, including LDHA (ab93699), MDH1
(ab99244), MDH2 (ab99238), IDH1 (ab113858), and PHGDH (ab198455). Substrates,
cofactors, and inhibitors were purchased from Sigma, including pyruvate, oxaloacetate,
alpha-ketoglutarate, dimethyl-alpha-ketoglutarate, L-lactate, D-lactate, L-malate, D-malate,
L-2-hydroxyglutarate, D-2-hydroxyglutarate, alpha-ketobutyrate, oxopentanoic acid,
oxoadipic acid, ketohexanoic acid, phenylpyruvate, hydroxyphenylpyruvate, NADH,
NADPH, and oxamate. FLAG-tagged wildtype and Q100R mutant LDHA constructs were
cloned into the PCDNA3.1(+) vector (Addgene) by standard site-directed mutagenesis and
verified by Sanger sequencing.
Cell Culture

Author Manuscript

Adherent cell lines 293T (purchased from ATCC) and SFXL (SF188 cells with stable
expression of Bcl-XL; generated as previously described51) were maintained at low passage
number in high glucose DMEM with 10% FBS, glucose 25 mM, glutamine 4 mM, penicillin
100 units/ml, and streptomycin 100 μg/ml and split every 2–3 days before reaching
confluence. Cell lines were authenticated by Short Tandem Repeat (STR) profiling. Cell
lines repeatedly tested negative for mycoplasma throughout the experimental period. For
siRNA experiments, cells were reverse-transfected with siRNA mixed with Lipofectamine
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RNAiMAX (Life Technologies) in Opti-MEM Reduced Serum Medium (Life Technologies)
as described by the manufacturer. The following siRNAs (ThermoFisher) were used:
siLDHA = J-008201-06, target sequence: GGCAAAGACUAUAAUGUAA; siMDH2 =
J-008439-12, target sequence: CGCCUGACCCUCUAUGAUA. For experiments with
acidified medium, standard DMEM was titrated to pH 6.0 at room temperature and
atmospheric oxygen then filtered through a sterile 0.2 μm filter prior to use in tissue culture.
Western Blotting

Author Manuscript
Author Manuscript

Cell lysates were extracted in 1× RIPA buffer (Cell Signaling), sonicated, centrifuged at
21,000 g at 4° C, and supernatants were collected. Nuclear extracts were prepared by
harvesting cells in NaCl 50 mM, sucrose 0.5 M, Triton × 0.5% plus protease/phosphatase
inhibitor cocktail (ThermoFisher). Isolated nuclei were washed with KCl 10 mM then lysed
in NaCl 500 mM and NP-40 0.1%. Cleared cell lysates or nuclear extracts were quantified
by BCA assay (ThermoFisher) and normalized for total protein concentration. Samples were
separated by SDS-PAGE, transferred to nitrocellulose membranes (Life Technologies),
blocked in 5% milk prepared in Tris buffered saline with 0.1% Tween 20 (TBST), incubated
with primary antibodies overnight at 4° C then horseradish peroxidase (HRP)-conjugated
secondary antibodies (GE Healthcare; anti-mouse, NA931V, sheep, 1:5000; anti-rabbit,
NA934V, donkey, 1:5000) for 1 hr the following day. After incubation with ECL
(ThermoFisher or GE Healthcare), imaging was performed using the Amersham Imager 600
(GE Healthcare). Primary antibodies used included: anti-Ezh2 (Cell Signaling, 5246P;
rabbit; 1:1000), anti-HIF-1α (BD Biosciences, 610959; mouse; 1:200), anti-hydroxylHIF-1α (Cell Signaling, 3434P; rabbit; 1:1000), anti-IDH1 (Proteintech, 12332-1-AP;
rabbit; 1:1000), anti-IDH2 (Abcam, ab55271; mouse; 1:1000) anti-LDHA (Cell Signaling,
2012S; rabbit; 1:1000), anti-MDH2 (Abcam, ab96193; rabbit; 1:1000), anti-alpha-tubulin
(Sigma, T9026: mouse; 1:5000), and anti-vinculin (Abcam, ab18058; mouse; 1:1000).
Intracellular pH Measurement

Author Manuscript

Cells were loaded with either 5-(and-6)-Carboxy, Acetoxymethyl Ester, Acetate (SNARF-1;
Thermo) or 2′,7′-Bis-(2-Carboxyethyl)-5-(and-6)-Carboxyfluorescein, Acetoxymethyl Ester
(BCECF; Thermo) ratiometric pH probes according to the manufacturer’s instructions. After
loading with pH probe, cells were incubated in DMEM without phenol red that was either
left unmanipulated or titrated to pH 6.0 with addition of either DMSO (vehicle) or dimethylαKG 5 mM. After 4 hours of incubation at 37° C with 5% CO2, fluorescence was measured
using a plate reader (Tecan, Infinite M1000). The SNARF-1 probe was detected with a
single excitation at 514 nm and a dual-emission ratio (580 nm and 640 nm). The BCECF
probe was detected with a dual-excitation (490 nm and 440 nm) and a fixed emission
wavelength of 535 nm. Background fluorescence (cells without probes) was subtracted
before all calculations. Intracellular pH was quantified by a standard curve ranging from pH
5.5 to pH 7.5 using DMEM with nigericin 10 μM and valinomycin 10 μM to equilibrate
intracellular pH with extracellular pH.
Enzyme Assays
Enzyme reactions were conducted in potassium phosphate buffer 33 mM titrated to pH 7.4,
7.0, 6.6, or 6.0. Purified enzymes were used at 5 units/ml, 1 μg/ml, or 10 μg/ml as indicated,
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and recombinant enzymes were used at 15 μg/ml unless otherwise indicated. FLAG-tagged
wildtype and Q100R mutant LDHA enzymes were purified from transfected 293T cells
using Anti-FLAG M2 Affinity Gel (Sigma) according to the manufacturer’s instructions.
FLAG-tagged enzymes were quantified by BCA assay and gel electrophoresis with
Coomassie staining. NADH and NAPDH were used at 0.22 mM or 0.30 mM respectively
throughout unless otherwise indicated. Substrates were used at 1 mM unless otherwise
indicated. For NADH consumption assays, reactions were conducted in UV-transparent 96well plates (Corning) with reaction volumes of 200 μl. A SpectraMax Plus 384 Microplate
Reader (Molecular Devices) was used to monitor the absorbance at 340 nm every 30 seconds
or 12 seconds throughout the course of the reaction. For each condition, the mean rate of
NADH consumption for triplicate control reactions without enzyme was subtracted from the
rate of NADH consumption for triplicate experimental reactions with enzyme. Reaction
velocities were calculated using an extinction coefficient for NADH at ε340 of 6220 M−1
cm−1 and pathlength of 0.56 cm for a 200 μl reaction volume in a standard 96-well plate. For
NADH consumption assays with purified LDH and pyruvate, reactions were conducted in
UV-transparent 3-ml cuvettes (BrandTech; pathlength 1 cm) with measurement of the
absorbance at 340 nm every 2 seconds. For cell lysate enzyme assays, SFXL cells were
cultured in normoxic conditions in regular DMEM medium and harvested at subconfluence.
The harvested cells were divided into 4 equal fractions, and non-denaturing cell lysates were
prepared with PBS plus 0.1% Triton X titrated to pH 7.5, 7.0, 6.5, or 6.0 and used at either
50 or 100 μl per 200 μl reaction with αKG and NADH. The reaction mixtures were stopped
after 16 hr, at which time metabolites were extracted, derivatized and analyzed by GC- or
LC-MS.
Metabolite Extraction and Analysis
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Metabolites were extracted with ice-cold 80:20 methanol:water containing 2 μM deuterated
2-hydroxyglutarate (D-2-hydroxyglutaric-2,3,3,4,4-d5 acid; deuterated-2HG) as an internal
standard. After overnight incubation at −80° C, cell extract was harvested, sonicated, and
centrifuged at 21,000 g for 20 min at 4° C to precipitate protein. Extracts were then dried in
an evaporator (Genevac EZ-2 Elite). For GC-MS, metabolites were resuspended by addition
of 50 μl of methoxyamine hydrochloride (40 mg/ml in pyridine) and incubated at 30° C for
90 min with agitation. Metabolites were further derivatized by addition of 80 μl of MSTFA
+ 1% TCMS (Thermo Scientific) and 70 μl of ethyl acetate (Sigma) and incubated at 37° C
for 30 min. Samples were diluted 1:2 with 200 μl of ethyl acetate, then analyzed using an
Agilent 7890A GC coupled to Agilent 5975C mass selective detector. The GC was operated
in splitless mode with constant helium carrier gas flow of 1 ml/min and with a HP-5MS
column (Agilent Technologies). The injection volume was 1 μl and the GC oven temperature
was ramped from 60° C to 290° C over 25 min. Peaks representing compounds of interest
were extracted and integrated using MassHunter software (Agilent Technologies) and then
normalized to both the internal standard (deuterated-2HG) peak area and protein content as
applicable. Ions used for quantification of metabolite levels were 2HG m/z 247
(confirmatory ion m/z 349), deuterated-2HG m/z 252 (confirmatory ion m/z 354), malate
m/z 335 (confirmatory ions m/z 233, 245), and lactate m/z 190 (confirmatory ion m/z 219).
Peaks were manually inspected and verified relative to known spectra for each metabolite.
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For LC-MS, dried samples were derivatized with 100 μl of freshly prepared 50 mg/ml (+)diacetyl-L-tartaric anhydride (DATAN, Sigma) in dichloromethane-acetic acid (v/v=4:1) at
75° C for 30 min. After cooling to room temperature, derivatized samples were dried under
nitrogen at room temperature and resuspended in 200 μl of UltraPure water (18.2 MΩ,
PureLab) prior to LC-MS/MS analysis. Analysis was performed on a Thermo Vantage triplequadrupole mass spectrometer operating in SRM and negative ionization modes. LC
separation was using an Acquity UPLC HSS T3 analytical column (2.1×100 mm, 1.8 μm,
Waters) with an Agilent 1260 infinity binary pump. Mobile phase A was 125 mg/l
ammonium formate in water adjusted to pH 3.5 with formic acid, mobile phase B was
methanol, and flow rate was 0.3 ml/min. Initial conditions were 3% B for 5 min, then
increased to 80% B at 5.5 min and held for a further 2.5 min. 10 min of re-equilibration time
was used to ensure retention time stability. The column temperature was held at 40° C.
Samples were kept at 4° C and the injection volume was 5 μl. MS source parameters were
spray voltage: 2500 V; capillary temperature: 300° C; vaporizer temperature: 250° C; sheath
gas pressure: 50 psi; aux gas pressure: 40 psi. Compound specific S-lens values were: 37 V
(2HG), 36 V (malate), 34 V (lactate), 40 V (α-ketoglutarate), and 41 V (deuterated-2HG).
Individual reactions monitored and collision energies (CE) were: 2HG m/z 363.0 → 147.1
(CE: 12 V)*, 129.1 (CE: 27 V); malate m/z 349.0 → 133.0 (CE 14 V)*, 115.0 (CE 28 V);
lactate m/z 305.0 → 89.1 (CE 14 V)*, α-ketoglutarate m/z 145.1 → 57.0 (CE 12 V); 113.0
(CE 16V); deuterated-2HG m/z 368.0 → 152.1 (CE 13 V)*, 132.9 (CE 22 V), with *
indicating the primary transition used to quantify each metabolite. Pure standards of L-2HG,
D-2HG, L-malate, D-malate, L-lactate, and D-lactate were derivatized and analyzed in
parallel for each chiral determination experiment. The identities of metabolite enantiomers
were determined by comparing to the retention times of the derivatized pure standards and
additionally confirmed by spike-ins of derivatized pure standards into the experimental
sample. Absolute metabolite quantitation was performed using an external calibration curve
with deuterated-2HG internal standard and the resulting concentrations corrected for the
total cell volume extracted. Chromatograms were acquired and processed with XCalibur and
TraceFinder software (ThermoFisher).
Aqueous solution pKa prediction
The aqueous solution
values for the tail carboxylate moiety of αKG were predicted
using Epik (Schrödinger Release 2015-3)52 using default settings.
Virtual docking of αKG to LDHA
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Virtual docking of αKG was performed using Glide XP (Schrödinger release 2015-3)53,54 to
chain A of the 2.1 Å structure of lactate dehydrogenase A (LDHA pdb identifier: 4OKN55).
Missing side chains were automatically constructed, amino acids were assigned protonation
states compatible with a pH of 7.0 using the protein preparation wizard (Schrödinger release
2015-3), and crystallographic waters were removed. Bond orders for NADH were manually
verified to avoid misassignment. Oxalate was used as a reference ligand to define the
binding site, after adding fictitious atoms to ensure minimum atom requirement for binding
site definition was met. Hydroxyl and thiol groups were allowed to rotate during grid
generation. The tail-protonated form of αKG was docked in the presence of crystallographic
NADH. Docking poses were minimized post-docking. The resulting conformations were
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clustered within a 0.5 Å RMSD cutoff. This resulted in a single representative pose. All
steps utilized default parameters unless otherwise noted. Poses and predicted hydrogen
bonds were visualized using PyMOL.
Monte Carlo protonation state modeling using MCCE2 simulations
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MCCE256 was used to perform Monte Carlo simulations of amino acid side chain position
and side chain and substrate protonation at equilibrium. The 2.3 Å structure of lactate
dehydrogenase A (LDHA pdb identifier: 1I1057) was used as input for all calculations (~60
computational hours at two Intel® Xeon™ 2.40 GHz Six Core CPU). αKG was modeled
using a virtually docked pose from previous work17. This structure was prepared using the
same docking procedure as detailed in this paper. The protonation states were compared
between structures with the coenzyme and substrate (NADH and αKG) bound to LDHA or
removed. The same starting protein structure was used for both bound and unbound types of
simulation. The simulations were performed between pH 4.0–10.0 at intervals of 1.0 pH
unit, and at pH 6.6 and 7.4. The total number of MC steps for the equilibration at each pH
was 480000. MCCE2 explores all side chain rotamers. DelPhi58 was used to solve the
Poisson Boltzmann equation to obtain the pairwise interactions between charged and/or
polar groups and the solvation energy with an internal dielectric constant of 4.0 and 80 for
the solvent, with 0.15 salt concentration. The atomic partial charges and radii for the amino
acids were obtained from PARSE59, while those of the ligands were generated by
QUACPAC (Openeye toolkit 2016-Jun.1). MCCE2 calculates how the protein modifies the
solution pKa (pKa,sol) of amino acids and substrates upon transfer into its position in the
protein. NADH, and αKG protonation states and tautomers, including their relative
populations were generated and performed using Epik (Schrödinger Release 2015-3).
Relative Epik energies were calculated at pH 4.0–10.0 at intervals of 1.0 pH unit, pH 6.6 and
pH 7.4. The energetic description for amino acids or standard ligands includes the pKa,sol as
well as AMBER60 torsion energies and van der Waals self-interactions. For the substrate,
values were set to zero and the relative Epik energy of each tautomer and protonation state
provided the starting reference state in solution. MCCE2 then calculated the shift in relative
energy within the protein and thus showed the change in their distribution. The protein side
chain rotamers and protonation states were sampled along with the ligand tautomers and
protonation states at the given pH.
Data availability
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The docking and MCCE2 calculation data, including scripts, have been deposited in
“figshare” (https://dx.doi.org/10.6084/m9.figshare.4289894.v3). Inside the zip file, see the
‘Docking’ folder for files used in the docking procedures. Docking was performed using
Maestro as part of Schrodinger release 2015-3. See the ‘MCCE’ folder for files used for the
MCCE2 calculations for lactate dehydrogenase A. MCCE calculations were performed
using MCCE2 (https://sites.google.com/site/mccewiki/install-mcce). Epik calculations were
performed using Schrodinger release 2015-3.

Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. LDH and MDH enzymes catalyze reduction of the alternative substrate αKG

(a) Schematic of metabolic changes that occur in hypoxic cells. LDHA, MDH1, and MDH2
represent potential enzymatic sources of L-2HG production in cells. (b) Enzyme assay
measuring NADH consumption by LDH purified from bovine heart (5 units/ml) in reactions
with either no substrate (grey), pyruvate 0.3 mM (green), or αKG 1 mM (blue). (c) NADH
consumption by MDH purified from porcine heart (5 units/ml) in reactions with either no
substrate (grey), OAA 0.3 mM (orange), or αKG 3 mM (blue). Data in b and c are mean
± 95% c.i. for triplicate reactions. (d–f) Alpha-hydroxyacid product formation catalyzed by
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dehydrogenases. GC-MS analysis of (d) lactate production from pyruvate, (e) malate
production from oxaloacetate, or (f) 2HG production from αKG in 6 hr enzyme reactions
with either no enzyme, LDH purified from bovine heart (10 μg/ml), or MDH purified from
porcine heart (10 μg/ml). Reactions were conducted in potassium phosphate buffer 33 mM,
pH 7.0, with NADH 0.22 mM. Results throughout figure are representative of ≥3
independent experiments.
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Figure 2. LDH and MDH selectively produce L-alpha-hydroxyacids, including L-2HG
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(a–c) Chiral LC-MS analysis resolving enantiomers of (a) lactate produced from pyruvate,
(b) malate produced from oxaloacetate, or (c) 2HG produced from αKG in 6 hr reactions
with either no enzyme, LDH purified from bovine heart (5 units/ml), or MDH purified from
porcine heart (5 units/ml) in potassium phosphate buffer 33 mM, pH 7.0, with NADH 0.22
mM and 1 mM substrate. The top panels show mixtures of standards for L- and D-lactate,
malate, and 2HG that were derivatized and analyzed by the same method in parallel. Vertical
blue and red bars in background serve as visual references to facilitate identification of Land D- enantiomers, respectively. Results throughout figure are representative of ≥3
independent experiments.
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Figure 3. Acidic pH enhances L-2HG production by LDH and MDH

(a, b) Increased rates of NADH consumption in acidic reaction conditions with purified (a)
LDH or (b) MDH at 5 units/ml and αKG 3 mM. Data for a and b are mean ± 95% c.i. for
triplicate reactions. (c, d) Reaction velocities as a function of αKG concentration for
purified (c) LDH or (d) MDH at 5 units/ml. (e, f) Chiral LC-MS analysis of 2HG
enantiomers from 6 hr reactions with purified (e) LDH or (f) MDH at 5 units/ml and αKG 1
mM. (g) Reaction velocities as a function of pyruvate concentration for purified LDH at 1
μg/ml. (h) Chiral LC-MS analysis of lactate enantiomers from 6 hr reactions with purified
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LDH at 5 units/ml and pyruvate 1 mM. Reactions were in potassium phosphate buffer 33
mM at indicated pH with NADH 0.22 mM. Data for c, d, and g are mean ± s.d. for triplicate
reactions. Results throughout figure are representative of ≥3 independent experiments.
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Figure 4. LDH exhibits pH-sensitive reduction of alpha-ketoacids with carboxylate tails
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(a) Relative rates of NADH consumption at indicated pH with purified LDH 5 units/ml,
NADH 0.22 mM, and substrate 1 mM. For each substrate, the rate at pH 7.4 was normalized
to 1 to illustrate degree of rate enhancement with acidification. Structures for substrates
alpha-ketoglutarate (αKG), phenylpyruvate (PP), and hydroxyphenylpyruvate (HPP). (b)
Relative rates of NADH consumption at indicated pH with purified LDH 5 units/ml, NADH
0.22 mM, and substrate 1 mM. For each substrate, the rate at pH 7.4 was normalized to 1 to
illustrate degree of rate enhancement with acidification. Structures for alpha-ketoacid
substrates with carboxylate tails, oxaloacetate (OAA), αKG, oxoadipic acid (OAdA) along
with their respective methylated counterparts alpha-ketobutyrate (αKB), oxopentanoic acid
(OPA), and ketohexanoic acid (KHA). Data are mean ± s.d. for triplicate reactions. Results
throughout figure are representative of ≥3 independent experiments.
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Figure 5. Acidity-induced rate enhancement arises from preference of LDHA for protonated
form of αKG

(a) Virtually docked structure of deprotonated αKG (yellow) bound to LDHA, showing a
potentially unfavorable interaction between the carbonyl of the Q100 residue, and the tail of
αKG. (b) Virtually docked structure of protonated αKG (yellow) bound to LDHA, showing
a potential hydrogen-bond interaction between the carbonyl of the Q100 residue, and the
protonated carboxylate tail of αKG, predicted to be the dominant bound species by Monte
Carlo simulations. (c) The equilibrium of protonation states of the tail of αKG in solution.
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Shown on the right is the theoretical free energy penalty of protonating the tail at pH 7.4
(ΔGpH 7.4) and pH 6.0 (ΔGpH 6.0) in units of kBT where kB is the Boltzmann constant and T
is the absolute temperature. (d–f, g) Wildtype (WT) or mutant (Q100R) LDHA enzymes
were purified and used in enzymatic reactions with (d) alpha-ketoglutarate (αKG), (e)
oxaloacetate (OAA), (f) oxopentanoic acid (OPA), or (g) pyruvate (Pyr). Reactions were
performed in potassium phosphate buffer 33 mM at the indicated pH, NADH 0.22 mM, 1
mM substrate, and enzyme at (d, f) 7 μg/ml, (e) 0.7 μg/ml, or (g) 0.07 μg/ml. Data for d–g
are mean ± s.d. for triplicate reactions. Results throughout figure are representative of ≥3
independent experiments.
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Figure 6. Acid-enhanced production of L-2HG stabilizes HIF-1α
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(a) SFXL cells were lysed in non-denaturing conditions at indicated pH. Cell lysates were
incubated for 16 hr with αKG 1 mM and NADH 0.22 mM. Total 2HG was analyzed by GCMS. (b) Lysate reactions were prepared as in a with addition of either vehicle or oxamate 1
mM. L-2HG was measured by chiral LC-MS. Data are mean ± s.d. for triplicate reactions.
(c) SFXL cells were cultured for 24 hr in standard DMEM or DMEM titrated to pH 6.0
(‘acid’) with vehicle or cell-permeable dimethyl-αKG 5 mM. Total 2HG was measured by
GC-MS. Data are mean ± s.d. for triplicate wells. (d) Quantification of intracellular L- and
D-2HG concentrations by LC-MS (see Online Methods). Data are mean ± s.d. of a total of 6
replicates per condition from 2 independent experiments. (e) 293T cells were cultured for 24
hr as in c with addition of vehicle or MG132 10 μM for the final 1 hr. Western blotting of
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nuclear extracts shows HIF-1α, hydroxyl-HIF-1α, and Ezh2 (loading control). (f) LDHA
and MDH2 were targeted by siRNAs in SFXL cells followed by culture for 24 hr as in c.
Western blot for c used whole cell lysates, while e and f used nuclear extracts. Full blot
images for c, e and f are shown in Supplementary Fig. 11. Results for a–c and e are
representative of ≥3 independent experiments. Results for f are representative of 2
independent experiments.
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